Sumitomo Dainippon Pharma Co. Ltd. | Mutual Funds
Mutual Funds that own Sumitomo Dainippon Pharma Co. Ltd.
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
2.37%
128,000
0.39%
07/31/2018
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
1.2%
2,000
0.38%
08/20/2018
Daiwa Asset NIKKEI 225 ETF (1320)
4,228,000
1.06%
-16,000
0.38%
07/31/2018
Vanguard Total International Stock Index Fund
2,376,612
0.6%
61,200
0.01%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
2,340,800
0.59%
37,100
0.07%
07/31/2018
Mitsubishi UFJ MAXIS Nikkei 225 ETF (1346)
2,294,000
0.57%
46,000
0.38%
07/31/2018
Government Pension Fund - Global (The)
2,221,759
0.56%
-551,001
0.01%
12/31/2017
Daiwa Asset TOPIX Listed ETF (1305)
1,149,100
0.28%
25,900
0.07%
07/31/2018
Canada Pension Plan
1,147,000
0.28%
-262,000
0.01%
03/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
1,054,300
0.27%
0
0.07%
08/20/2018
| Address |
2-6-8 Dosho-machi
Osaka Osaka 541
Japan
|
|
Employees
|
- |
| Website |
http://www.ds-pharma.co.jp |
| Updated |
07/08/2019 |
| Sumitomo Dainippon Pharma Co., Ltd. engages in manufacturing, sale, import and export of pharmaceuticals products. It operates through the Pharmaceutical Business and Other Business segments. The Pharmaceutical Business segment handles the creation of new pharmaceutical products. |
